K260234 is an FDA 510(k) clearance for the MSK Go. Classified as Automated Radiological Image Processing Software within the QIH classification (a category dominated by AI-based automated radiology processing systems), Class II - Special Controls.
Submitted by Smart Alfa Teknoloji San. Ve Tic. A.S. (Ankara, TR). The FDA issued a Cleared decision on May 21, 2026 after a review of 115 days - within the typical 510(k) review window.
This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.
View all Smart Alfa Teknoloji San. Ve Tic. A.S. devices
NCT07336407
Completed
Interventional
Industry-sponsored
Data Collection for the Validation of an Artificial Intelligence Software to Support Musculoskeletal Ultrasound Examination
Data Collection for the Validation of an AI Software to Support MSK Ultrasound Examination
| Condition studied |
Ultrasound Imaging of Anatomical Structures |
| Study design |
Single group |
| Eligibility |
All sexes
· 18 Years+
· Healthy volunteers accepted
|
| Sponsor |
Smart Alfa Teknoloji San. ve Tic. A.S.
(industry)
|
Started 2025-09-01
→
Primary completion 2025-10-31
→
Completed 2025-11-30
Primary outcome
Rate of spatial (area) overlap of anatomical structure areas on the ultrasound image
Secondary outcome
Rate of correctly assigning anatomical structure completeness level for any scan view of the joint
Study completed - no results published.
This trial concluded in 2025 but has not posted
results to ClinicalTrials.gov. Completed studies without public results are common
in industry-sponsored device trials; the data may be referenced in the
510(k) Summary PDF or remain unpublished.
Individual participant data will not be shared.
View full study on ClinicalTrials.gov